Lynk Pharmaceuticals Announces NMPA Acceptance of New Drug Application for Zemprocitinib in the Treatment of Rheumatoid Arthritis
SHANGHAI and HANGZHOU, China and BOSTON, Nov. 5, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, announced...
Lean: Not rated
Fact-focusedCountry: United States
Coverage breakdown
Funding
Not recorded
Countries
United States
Media ownership
Amherst Bee
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: Not rated
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 8
Amplification: 0